ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 752329 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 752329; 2) Community: the network communities that were significantly associated with the response to NSC 752329; 3) Molecule: the relationships between components within communities and NSC 752329; 4) MDR: the compounds that were significantly associated with the NSC 752329.

NSC Compound Enrichment Correlation
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0201565205286441 -0.000378051
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0201565205286441 0.024839894
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0201565205286441 0.092365207
NSC 732178 Null 0.0201565205286441 0.010102991
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.0201565205286441 0.067312827
NSC 736157 Null 0.0201565205286441 -0.041856043
NSC 736802 Null 0.0201565205286441 0.017071253
NSC 736811 Null 0.0201565205286441 -0.078576203
NSC 737231 Null 0.0201565205286441 -0.19053882
NSC 740 Methotrexate 0.0201565205286441 0.15015039
Total:136  Current:73    [First] [Prev] [Next] [Last]